A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly ...
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...
Study reveals B cells suppress mutations during rapid division, enhancing immune response and offering critical insights for ...
Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.
DR-0201 is a potential first-in-class CD20-directed bispecific antibody that targets and engages specific tissue-resident and trafficking myeloid cells to induce deep B-cell depletion via targeted ...
In contrast to polyclonal antibodies, monoclonals are highly specific to an antigen. By fusing myeloma cells that can divide indefinitely with B cells that produce specific antibodies against the ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
ImmunoPrecise Antibodies ... Ph.D., said in the release. “With the purchase order secured and work already underway, we are actively leveraging our proprietary B-cell Select platform and LENS ...